A detailed history of Wp Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wp Advisors, LLC holds 1,480 shares of NVO stock, worth $162,992. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,480
Holding current value
$162,992
% of portfolio
0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $181,610 - $217,426
1,480 New
1,480 $211,000
Q2 2019

Jul 23, 2019

SELL
$46.79 - $52.47 $34,624 - $38,827
-740 Closed
0 $0
Q1 2019

Apr 15, 2019

BUY
$46.36 - $52.63 $34,306 - $38,946
740 New
740 $387,000
Q4 2018

Jan 18, 2019

SELL
$41.54 - $47.25 $39,047 - $44,415
-940 Closed
0 $0
Q2 2018

Jul 27, 2018

BUY
$44.29 - $50.42 $41,632 - $47,394
940 New
940 $43,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wp Advisors, LLC Portfolio

Follow Wp Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wp Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wp Advisors, LLC with notifications on news.